Citigroup’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-14,945
Closed -$65.2K 6118
2025
Q4
$65.2K Buy
14,945
+14,944
+1,494,400% +$80.7K ﹤0.01% 4488
2025
Q3
$4 Buy
+1
New +$4 ﹤0.01% 5993
2025
Q1
Sell
-8
Closed -$19 5723
2024
Q4
$19 Hold
8
﹤0.01% 5751
2024
Q3
$19 Sell
8
-2,685
-100% -$5.91K ﹤0.01% 5597
2024
Q2
$5.25K Sell
2,693
-773
-22% -$2.63K ﹤0.01% 5253
2024
Q1
$22.3K Buy
3,466
+813
+31% +$7.38K ﹤0.01% 5000
2023
Q4
$37.2K Buy
2,653
+2,651
+132,550% +$41.8K ﹤0.01% 4674
2023
Q3
$49 Sell
2
-820
-100% -$20.8K ﹤0.01% 5527
2023
Q2
$26.9K Sell
822
-2,209
-73% -$62.1K ﹤0.01% 4881
2023
Q1
$84.1K Buy
+3,031
New +$49.1K ﹤0.01% 4092

Other funds holding GNLX

Citigroup's GNLX Position: Q1 2026 in Review

Citigroup sold out of Genelux (GNLX) in Q1 2026, closing a stake of 14,945 shares — an estimated $65.2K sold.

Citigroup first reported a position in GNLX in Q1 2023 and held it in 10 quarters. The position peaked at $84.1K in Q1 2023. 71 funds tracked by Wall St. Rank hold GNLX as of Q1 2026.

  • Citigroup reported no remaining Genelux position as of Q1 2026 after selling out during the quarter.
  • Citigroup sold 14,945 Genelux shares in Q1 2026, an estimated $65.2K.
  • Citigroup first reported a position in Genelux in Q1 2023 and held it in 10 quarters.
  • Citigroup's Genelux position peaked at $84.1K in Q1 2023.
  • 71 funds tracked by Wall St. Rank held Genelux as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.